Better Trials
We help life-sciences companies design and deliver faster, more efficient and more informative clinical studies using innovative statistical methods.
Better trials through better statistics
Clinical development is expensive, time-consuming and full of uncertainty. Conventional trial designs do not always make the best use of accumulating data, existing evidence or advances in statistical methodology.
Better Trials helps life sciences companies apply innovative statistical approaches to make clinical development more efficient, more informative and better
aligned to key development decisions.
From protocol development through to interim and final analysis, we help partners move innovative designs into real-world studies.
Solving high-value problems
Better Trials links our research expertise to solve high-value problems in drug development.
We support companies to utilise efficient statistical design and analysis approaches in their clinical development plans to achieve:
- faster trials
- better evidence
- smarter decisions
Expertise you can trust
Led by internationally recognised researchers in innovative clinical trial methodology, Better Trials gives you direct access to specialist expertise.
The team is embedded within the Newcastle University Biostatistics Research Group, one of the UK’s leading academic centres for the development and implementation of efficient clinical trial designs.
Meet the team
Professor James Wason
James is Professor of Biostatistics at Newcastle University. He has more than 15 years’ experience developing, evaluating and implementing innovative clinical trial designs. With more than 200 research papers and has worked extensively with clinical and industry collaborators to apply novel statistical methods in real-world trials.
Dr David Sinclair
David is a Lecturer based in Newcastle University's Population Health Sciences Institute. He specialises in routinely collected data and electronic health records, including the Clinical Practice Research Datalink (CPRD) and the English Longitudinal Study of Ageing (ELSA). He uses real-world data to inform clinical trial design and generate robust evidence.
Dr Bethan Sayers
Bethan is an IP and Commercialisation Manager with extensive experience of business and university collaboration. She coordinates the commercial aspects of Better Trials projects, helping partners engage with the team and access the right expertise.